CSIMarket
 
Dupont De Nemours Inc   (DD)
Other Ticker:  
 
 
Price: $74.0300 $1.37 1.885%
Day's High: $74.25 Week Perf: 0.68 %
Day's Low: $ 71.25 30 Day Perf: -1.21 %
Volume (M): 4,741 52 Wk High: $ 87.27
Volume (M$): $ 350,947 52 Wk Avg: $57.19
Open: $73.80 52 Wk Low: $28.33



 Market Capitalization (Millions $) 54,390
 Shares Outstanding (Millions) 735
 Employees 35,000
 Revenues (TTM) (Millions $) 20,397
 Net Income (TTM) (Millions $) -2,923
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Dupont De Nemours Inc
DuPont was founded in 1802 and was incorporated in Delaware in 1915. DuPont is a world leader in science and technology in a range of disciplines, including high-performance materials, synthetic fibers, electronics, specialty chemicals, agriculture and biotechnology. The company operates globally, manufacturing a wide range of products for distribution and sale to many different markets, including the automotive, textile, construction, agricultural, medical, packaging, electronics, and the nutrition and health markets.


   Company Address: 974 Centre Road Wilmington 19805 DE
   Company Phone Number: 774-3034   Stock Exchange / Ticker: NYSE DD
   DD is expected to report next financial results on April 20, 2021. Next quarterly dividend pay out on March 12, 2021.


Customers Net Income grew by DD's customers Net margin grew to

15.74 %

9.33 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
UFI        5.58% 
TSE        3.65% 
ASIX        2.73% 
AVNT        8.61% 
ABT   -2.11%    
PG        1.98% 
• View Complete Report
   



Silvercrest Asset Management Group Inc

A $9.95 million tax benefit, helped Silvercrest Asset Management Group Inc to post $0.20 eps in the fourth quarter of 2020

A $9.95 million tax benefit, helped Silvercrest Asset Management Group Inc to post $0.20 eps in the fourth quarter of 2020

From the preceding quarter, eps decreased from $0.22 per share and Sales advanced by 7.84 % from $27.18 millions.
In the fiscal year 2020, Silvercrest Asset Management Group Inc reported Sales of $108.89 millions and net income of $17.48 millions.

Income improved by 7.14 % to $1.05 per share from $0.98 in the previous fiscal year, while Sales increased by 4.61 % from $104.10 millions a year ago.

Syros Pharmaceuticals inc

Company Fail to Break-even Despite Surge in Sales

Syros Pharmaceuticals Inc announced very strong Sales growth of 1021.65% year on year to $5.70 millions in the fourth quarter of 2020, but increased losses at $-0.62.

compared to previous quarter increased losses from $-0.43 per share and Sales surged by 48.85 % from $3.83 millions.
Syros Pharmaceuticals Inc reported net loss of $-84.04 millions and Sales of $15.09 millions for the fiscal year 2020.

Company has decreased loss per share to $-1.82 from $-1.88 in the previous fiscal year, while Sales doubled by 661.5 % from $1.98 millions a year ago.

Kadmon Holdings Inc

Kadmon Holdings Inc announced financial period ending Dec 31 2020 operating loss of $-31.239 millions

Kadmon Holdings Inc reported disastrous financial period ending Dec 31 2020, where Sales faded by -86.03% to $0.62 millions and loss per share has widen to $-0.16, from the same quarter a year ago.

Eps decreased from the preceding quarter from $-0.15 per share, Sales improved by 25.51 % from $0.49 millions.
Kadmon Holdings Inc reported net loss of $-108.91 millions and Sales of $8.29 millions for the fiscal year 2020.

Net loss per share has widen to $-0.67 from $-0.48 in previous fiscal year, while Sales surged by 62.67 % from $5.10 millions a year ago.

Tortec Group Corp

Tortec Group Corp announced financial third quarter of 2020 operating deficit of $-0.03406 millions

Tortec Group Corp announced operating shortfall of $-0.03406 millions, in the financial third quarter of 2020, an advancement from the operating shortfall of $-0.073358 millions, recorded in the same quarter a year ago.


Vyne Therapeutics Inc

Vyne Therapeutics Inc announced most recent fiscal period operating income of $21.989 millions

In the most recent fiscal period Vyne Therapeutics Inc earnings turn positive of $0.17 per share compared to $-0.89 a year ago and income per share increased by 11.46 % from $0.15 per share from the previous quarter.

Sales remained unchanged to $4.29 millions from $0.00 millions in the same quarter a year ago and sequentially Sales surged by 31.11 % from $3.27 millions.
Vyne Therapeutics Inc reported earnings of $255.57 millions and Sales of $20.99 millions for the fiscal year 2020.

Company reported earnings per share of $7.88 compared to $-3.09 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.






 

Dupont De Nemours Inc 's Segments
 
Agriculture
 Segment    21.73 % of total Revenue
Coatings & Color Technologies
 Segment    25.89 % of total Revenue
Electronic & Communication Technologies
 Segment    10.58 % of total Revenue
Performance Materials
 Segment    16.52 % of total Revenue
Safety & Protection
 Segment    3.1 % of total Revenue
Nutrition & Health
 Segment    16.11 % of total Revenue
Industrial Biosciences
 Segment    6.06 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Dupont De Nemours Inc does not provide revenue guidance.

Earnings Outlook
Vyne Therapeutics Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
North America 43.61 %
Europe & Others 24.43 %
Asia Pacific 22.18 %
South America 9.78 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MORN's Profile

Stock Price

MORN's Financials

Business Description

Fundamentals

Charts & Quotes

MORN's News

Suppliers

MORN's Competitors

Customers & Markets

Economic Indicators

MORN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071